New Zealand markets close in 4 hours 2 minutes

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
269.65-1.19 (-0.44%)
At close: 04:00PM EDT
274.00 +4.35 (+1.61%)
After hours: 07:31PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 66.14B
Enterprise value 58.77B
Trailing P/E 27.28
Forward P/E 17.95
PEG ratio (5-yr expected) 0.38
Price/sales (ttm)8.42
Price/book (mrq)6.06
Enterprise value/revenue 7.39
Enterprise value/EBITDA 19.22

Trading information

Stock price history

Beta (5Y monthly) 0.55
52-week change 330.64%
S&P500 52-week change 3-5.29%
52-week high 3292.75
52-week low 3176.36
50-day moving average 3263.47
200-day moving average 3221.03

Share statistics

Avg vol (3-month) 31.66M
Avg vol (10-day) 31.55M
Shares outstanding 5255.76M
Implied shares outstanding 6N/A
Float 8255.12M
% held by insiders 10.26%
% held by institutions 194.03%
Shares short (12 May 2022) 43.58M
Short ratio (12 May 2022) 41.97
Short % of float (12 May 2022) 41.40%
Short % of shares outstanding (12 May 2022) 41.40%
Shares short (prior month 13 Apr 2022) 44.1M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 323 Aug 2000

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 30.84%
Operating margin (ttm)36.85%

Management effectiveness

Return on assets (ttm)13.88%
Return on equity (ttm)24.65%

Income statement

Revenue (ttm)7.95B
Revenue per share (ttm)30.97
Quarterly revenue growth (yoy)21.60%
Gross profit (ttm)3.62B
Net income avi to common (ttm)2.45B
Diluted EPS (ttm)9.48
Quarterly earnings growth (yoy)16.70%

Balance sheet

Total cash (mrq)8.24B
Total cash per share (mrq)32.21
Total debt (mrq)872.5M
Total debt/equity (mrq)8.00
Current ratio (mrq)4.75
Book value per share (mrq)42.68

Cash flow statement

Operating cash flow (ttm)2.68B
Levered free cash flow (ttm)1.88B